Ensaios clínicos de Obesidade em Ohio
47 estudos para Obesidade estão buscando participantes em locais em Ohio.
Cidades em Ohio
Texto oficial do estudo (Inglês)
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Velocity Clinical Research, Cincinnati, Springdale, Cincinnati
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT07783802A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
- Centricity Research - Ohio, Columbus
- PriMed Clinical Research, Dayton
RecrutandoFase 3
Idades de 8 a 18 · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT07253285Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
- CTI Clinical Research Center /ID# 282043, Cincinnati
RecrutandoFase 2
Idades de 18 a 75 · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT07752979A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- Midwest Eye Center, Cincinnati
- Velocity Clinical Research, Mt. Auburn, Cincinnati
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT07595549Comparing Reduction With ESD- Versus APC-TORe
- Cleveland Clinic Foundation, Cleveland
RecrutandoVoluntários saudáveis bem-vindos
Idades 18 e acima · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT06131281Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D
- Ohio Clinical Trials, Columbus
RecrutandoFase 1
Idades de 18 a 65 · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT07399678A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
- Research Site, Columbus
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT07776509A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
- Cleveland Clinic, Cleveland
- Nationwide Children's Hospital, Columbus
RecrutandoFase 3
Idades de 6 a 17 · Todos os sexos · Atualizado em 24 de set. de 2026 · NCT06672549Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Gastro Intestinal Research Institute of Northern Ohio, LLC, Westlake
RecrutandoFase 3
Idades de 18 a 70 · Todos os sexos · Atualizado em 24 de set. de 2026 · NCT06937086Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Gastro Intestinal Research Institute of Northern Ohio, LLC, Westlake
RecrutandoFase 3
Idades de 18 a 70 · Todos os sexos · Atualizado em 24 de set. de 2026 · NCT06937099A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- Care Access - Lima, Lima
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07282600Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- Velocity Clinical Research - Cleveland, Beachwood
- Aultman Hospital, Cardiovascular Consultants, Inc, Canton
- Velocity Clinical Research - Auburn, Cincinnati
- e mais 2
RecrutandoFase 3
Idades de 45 a 99 · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07037433A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, Kent
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07784270A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
- CTI Clinical Research Center, Cincinnati
RecrutandoFase 2
Idades de 18 a 75 · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07589608A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
- CTI Clinical Research Center, Cincinnati
- Care Access - Lima, Lima
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07392190A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
- CTI Clinical Research Center, Cincinnati
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07369011A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Cincinnati
- AURORA-2 Clinical Site, Cleveland
- AURORA-2 Clinical Site, Columbus
- e mais 1
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 16 de set. de 2026 · NCT07743450A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
- AURORA-1 Clinical Site, Cincinnati
- AURORA-1 Clinical Site, Cleveland
- AURORA-1 Clinical Site, Columbus
- e mais 1
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 16 de set. de 2026 · NCT07743463A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Remington Davis Inc, Columbus
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 14 de set. de 2026 · NCT07351058A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- Hometown Urgent Care and Research - Dayton, Dayton
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 14 de set. de 2026 · NCT07351045A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
- Providence Health Partners-Center for Clinical Research, Dayton
RecrutandoFase 2
Idades de 18 a 75 · Todos os sexos · Atualizado em 14 de set. de 2026 · NCT06897475A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
- ACCOMPLISH-2 Research Site, Columbus
RecrutandoFase 3Voluntários saudáveis bem-vindos
Idades de 18 a 79 · Todos os sexos · Atualizado em 11 de set. de 2026 · NCT07654374AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
- CTI Clinical Research Center, Cincinnati
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 11 de set. de 2026 · NCT07571005AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
- CTI Clinical Research Center, Cincinnati
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 9 de set. de 2026 · NCT07571109A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
- PriMED Clinical Research, Dayton
RecrutandoFase 2
Idades de 18 a 75 · Todos os sexos · Atualizado em 8 de set. de 2026 · NCT07215559A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
- CTI Clinical Research Center, Cincinnati
RecrutandoFase 2
Idades de 18 a 75 · Todos os sexos · Atualizado em 8 de set. de 2026 · NCT06143956A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
- Optima Research - Boardman, Boardman
RecrutandoFase 4
Idades 18 e acima · Todos os sexos · Atualizado em 4 de set. de 2026 · NCT06857942Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
- Kailera Clinical Site, Cleveland
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 3 de set. de 2026 · NCT07284901Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
- Clinical Trial Investigator Clinical Research Center, Cincinnati
- Velocity Clinical Research - Cincinnati, Cincinnati
RecrutandoFase 3
Idades de 18 a 99 · Todos os sexos · Atualizado em 3 de set. de 2026 · NCT07684235Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
- Velocity Clinical Research - Cincinnati, Cincinnati
- Velocity Clinical Research - Springdale, Cincinnati
RecrutandoFase 3
Idades de 18 a 99 · Todos os sexos · Atualizado em 3 de set. de 2026 · NCT07684144A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
- Research Site, Columbus
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 25 de ago. de 2026 · NCT07784725Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
- Cincinnati Children's Hospital Medical Center, Cincinnati
RecrutandoFase 2
Idades de 7 a 25 · Todos os sexos · Atualizado em 19 de ago. de 2026 · NCT05082519A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
- Aultman Hospital, Canton
- Lindner Center,Christ Hospital, Cincinnati
- Louis Stokes Clvlnd VA Med Ctr, Cleveland
- e mais 4
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 18 de ago. de 2026 · NCT07567001Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
- ACCOMPLISH-1 Research Site, Columbus
- ACCOMPLISH-1 Research Site, Columbus
RecrutandoFase 3
Idades de 18 a 79 · Todos os sexos · Atualizado em 10 de ago. de 2026 · NCT07654361Atomoxetine in Melanocortin Obesity Syndrome
- Nationwide Children's Hospital, Columbus
RecrutandoFase 2
Idades 6 e acima · Todos os sexos · Atualizado em 7 de ago. de 2026 · NCT06899178Fibrosis Lessens After Metabolic Surgery
- Cleveland Clinic, Cleveland
RecrutandoFase 4Voluntários saudáveis bem-vindos
Idades de 18 a 75 · Todos os sexos · Atualizado em 31 de jul. de 2026 · NCT06374875Determination of Resistance Training Status for Patients on Glucagon-Like Peptide-1 Receptor Agonists
- The Ohio State University, Columbus
RecrutandoEstudo observacional
Idades 18 e acima · Todos os sexos · Atualizado em 24 de jul. de 2026 · NCT07702461A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia
- Ohio Clinical Trials, Columbus
RecrutandoFase 2
Idades de 18 a 80 · Todos os sexos · Atualizado em 22 de jul. de 2026 · NCT07477704A Single and Multiple Ascending Dose Study of HM17321 in Healthy and Obese Participants
- Medpace Clinical Pharmacology Unit, Cincinnati
RecrutandoFase 1Voluntários saudáveis bem-vindos
Idades de 18 a 65 · Todos os sexos · Atualizado em 4 de mai. de 2026 · NCT07219589Dietary Peanuts and Nutrition-Related Outcomes
- University Hospitals Cleveland Medical Center, Clevland
RecrutandoVoluntários saudáveis bem-vindos
Idades de 18 a 80 · Todos os sexos · Atualizado em 23 de abr. de 2026 · NCT07244458Fonte: ClinicalTrials.gov, dados obtidos em 1 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.